meta_analysis
    2022
    High Quality

    Astaxanthin Influence on Health Outcomes of Adults at Risk of Metabolic Syndrome: A Systematic Review and Meta-Analysis

    Leung LY, Chan SM, Tam HL, Wong ES

    Published in Nutrients

    Methodology

    Systematic review and meta-analysis of 7 RCTs in adults with metabolic syndrome risk factors, 14 databases searched to June 2021, PEDro quality appraisal

    Key Findings

    Marginal reductions in total cholesterol and systolic blood pressure; a significant attenuating effect on LDL cholesterol.

    Conclusions

    Astaxanthin shows modest cardiometabolic effects in adults at risk of metabolic syndrome; more robust evidence is needed.

    Limitations

    Only 321 participants across 7 trials; several effects marginal; short interventions.

    Supplements Studied

    Astaxanthin
    Compound

    Results show marginal effects of astaxanthin on reduction in total cholesterol and systolic blood pressure, and a significant attenuating effect on low-density lipoprotein cholesterol

    Related Health Concerns

    Study Details

    Year:2022
    Sample Size:321
    Quality Score:7/10

    Disclosures

    Funding

    Not reported

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.